Associate Director, US Value and Access Strategy, Enzyme Therapies

United States·San Rafaelexecutive

OtherAssociate

0 views0 saves0 applied

Apply Now

Quick Summary

Overview

Who We Are BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions.

Key Responsibilities

Develop and execute U.S. market access strategies to support on-market products and new product launches. Lead payer engagement strategy, including national and regional commercial payers, PBMS, Medicare and Medicaid, for 2-3 Disease Areas.

Requirements Summary

US launch experience in specialty therapeutics (Oncology, rare disease, immunology) Experience with Medicare Part B/D, Medicaid and commercial payers Familiarity with ICER, QALY models, and evidence-based value frameworks Understanding of…

Technical Tools

OtherAssociate

Who We Are

BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based company has a proven track record of innovation, with multiple commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients..

About Commercial

Be part of the worldwide infrastructure that helps our medicines reach patients around the world. Our global sales force solidifies BioMarin’s commercial presence in the United States and Europe and has been growing in other regions across the globe.

Summary:

This is an exciting opportunity to partner closely with the rapidly growing US Enzyme Therapies Business Unit (BU) and to provide strategic input. As part of the US Pricing, Access, Value and Evidence (PAVE) team, the Associate Director, Market Access Strategy will drive US value, access, and reimbursement strategies to enable timely and sustainable patient access, coverage, and reimbursement for 2-3 disease areas within the Enzyme Therapies BU.

Reporting to the Sr. Director, U.S. Value and Access Strategy Lead, Enzyme Therapies, this individual will play a critical role in aligning cross functional teams, managing payer and channel strategies, and shaping the external market access environment to support product value and commercial success. This position works closely with multiple stakeholders within the commercial, medical affairs, and key corporate functions to objectively evaluate the US coverage and reimbursement environment and providing subject matter expertise to influence commercial planning and market entry plans. The position proactively identifies access issues and opportunities and collaborates with cross-functional leadership teams to develop and execute strategies that address barriers and enable market access success.

Responsibilities:

Develop and execute U.S. market access strategies to support on-market products and new product launches.
Lead payer engagement strategy, including national and regional commercial payers, PBMS, Medicare and Medicaid, for 2-3 Disease Areas.
Partner with pricing, HEOR, government affairs, patient services and field access teams to develop compelling value propositions and evidence plans.
Oversee the development of access-related tools and resources (AMCP dossiers, Payer value proposition decks, Health Care Economic Information for payers), including managing external agency vendors and acting as the Payer Marketing Lead.
Collaborate closely with the sales, marketing, medical affairs, and legal teams to ensure alignment on strategy and execution, representing PAVE at cross-functional forums
Support contracting strategy development and assist with negotiations as needed.
Manage relationships with external vendors, consultants and payer advisors.
Analyze access and utilization data to inform strategy and measure performance.

Required Experience/Skills:

Minimum 10+ years of progressive experience in US market access, managed markets, payer strategy or related pharmaceutical functions.
Deep understanding of U.S. healthcare system, reimbursement mechanisms, and payer landscape.
Deep understanding of health policy & health system environment for transformative and rare therapies.
Superior problem-solving skills, including demonstrated capability of applying previous experience to complex policy issues.
Excellent communication, collaboration, influence, strategic and analytical skills are required.
Ability to lead cross-functional teams in a fast-paced, dynamic environment.

Preferred Qualifications:

US launch experience in specialty therapeutics (Oncology, rare disease, immunology)

Experience with Medicare Part B/D, Medicaid and commercial payers

Familiarity with ICER, QALY models, and evidence-based value frameworks

Understanding of value-based contracting and innovative reimbursement models

Education: Bachelors (preferably in life sciences or economic); MBA or MPH, preferred

This position is preferably located in BioMarin’s corporate offices in San Rafael, CA, but not required. Travel is approximately 25%.

This position has no direct reports

Note: This description is not intended to be all-inclusive, or a limitation of the duties of the position. It is intended to describe the general nature of the job that may include other duties as assumed or assigned.

Equal Opportunity Employer/Veterans/Disabled

An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.